{"id":115605,"date":"2020-12-03T10:26:37","date_gmt":"2020-12-03T10:26:37","guid":{"rendered":"http:\/\/ccs-website-wordpress.ind.ninja\/?page_id=115605"},"modified":"2023-06-21T15:42:39","modified_gmt":"2023-06-21T15:42:39","slug":"ccs-hsrlce-bi-lilly-ncci-cardiometabolic-research-award","status":"publish","type":"page","link":"https:\/\/ccs.ca\/ccs-research-awards\/ccs-hsrlce-bi-lilly-ncci-cardiometabolic-research-award\/","title":{"rendered":"CCS Cardiometabolic Research Award"},"content":{"rendered":"\n
\"\"<\/figure>\n\n\n\n

The Canadian Cardiovascular Society (CCS), Heart & Stroke \/ Richard Lewar Centre of Excellence in Cardiovascular Research (HSRLCE), the BI-Lilly Alliance, and Novo Nordisk have collaboratively created an award, entitled \u201cCCS\/HSRLCE\/BI-Lilly\/Novo Nordisk Cardiometabolic Research Award\u201d.<\/p>\n\n\n\n

This Award is intended for early career researchers (including PhDs and MDs) who are within five (5) years of their first faculty appointment at a Canadian academic institution, for a research project on any topic related to cardiometabolic disease.<\/p>\n\n\n\n

A single award of $30K will be awarded based on an independent peer review process. Funded research must be completed within 12 months from the start of funding.<\/p>\n\n\n\n

Call for Applications: Closed<\/mark><\/strong><\/strong><\/p>\n\n\n\n

\n
\n
\n
Past Award Recipients<\/a><\/div>\n<\/div>\n<\/div>\n\n\n\n
\n
\n
Award Handbook<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
\n\n\n\n

Eligibility<\/span><\/strong><\/p>\n\n\n\n